Interleukin 6 at reperfusion: A potent predictor of hepatic and extrahepatic early complications after liver transplantation.

Francois FaitotCamille BeschBenjamin LebasPietro AddeoBernard ElleroMarie-Lorraine Woehl-JaegleIzzie-Jacques NamerPhilippe BachellierGuy Freys

Published in: Clinical transplantation (2018)

IL-6 at reperfusion is a valid biomarker to predict long-term survival. Furthermore, it helps the interpretation of cytolysis in the prediction of early vascular complications.

Keyphrases

acute myocardial infarction
cerebral ischemia
risk factors
acute ischemic stroke
subarachnoid hemorrhage
brain injury
left ventricular
blood brain barrier